Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

March 31, 2013

Conditions
Male Hypogonadism
Interventions
DRUG

Testosterone

Intranasal testosterone

DRUG

Testosterone

Intranasal testosterone

Trial Locations (30)

14609

Rochester Clinical Research, Rochester

19046

The Clinical Trial Center, Jenkintown

23294

National Clinical Research, Richmond

23502

National Clinical Research - Norfolk, Norfolk

29464

Coastal Carolina Research Center Inc, Mt. Pleasant

32765

Compass Research East LLC, Oviedo

33126

Pharmax Research Clinic, Miami

33134

Clinical Research of South Florida, Coral Gables

33756

Innovative Research of West Florida, Clearwater

35235

Alabama Clinical Therapeutics LLC, Birmingham

35801

Medical Affiliated Research Center, Inc., Huntsville

36608

Coastal Clinical Research, Mobile

40509

Central Kentucky Research Associates, Lexington

42431

Commonwealth Biomedical Research LLC, Madisonville

61114

Center for Pharmaceutical Research, Kansas City

71106

Regional Urology LLC, Shreveport

73112

Lynn Health Science Institute, Oklahoma City

75234

Reseach Across America, Dallas

77062

Centex Research, Houston

77074

Clinical Trial Network, Houston

78229

Cetero Research, San Antonio

78756

Austin Center for Clinical Research, Austin

84120

Granger Medical Clinic, West Valley City

85712

Quality of Life Medical Research Center, Tucson

89104

Clinical Research Center of Nevada, Las Vegas

92844

SC Clinical Research Inc, Garden Grove

94598

Diablo Clinical Reseach Inc., Walnut Creek

98057

Rainier Clinical Research Center, Renton

98502

Capital Clinical Reseach Center, Olympia

02886

Omega Medical Research, Warwick

All Listed Sponsors
lead

Acerus Pharmaceuticals Corporation

INDUSTRY